These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35186709)

  • 1. MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.
    Papaioannou M; Chorti AG; Chatzikyriakidou A; Giannoulis K; Bakkar S; Papavramidis TS
    Front Oncol; 2021; 11():755097. PubMed ID: 35186709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
    Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
    PeerJ; 2016; 4():e2119. PubMed ID: 27350898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
    Chou CK; Liu RT; Kang HY
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer.
    Ruiz-Pozo VA; Cadena-Ullauri S; Guevara-Ramírez P; Paz-Cruz E; Tamayo-Trujillo R; Zambrano AK
    Front Med (Lausanne); 2023; 10():1139362. PubMed ID: 37089590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
    Dai D; Tan Y; Guo L; Tang A; Zhao Y
    Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
    Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
    Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of microRNAs as the risk factor of lymph node metastasis in papillary thyroid carcinoma: systematic review.
    Laukiene R; Jakubkevicius V; Ambrozaityte L; Cimbalistiene L; Utkus A
    Endokrynol Pol; 2021; 72(2):145-152. PubMed ID: 33970479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
    Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
    J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.
    Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B
    OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers.
    Mutalib NS; Yusof AM; Mokhtar NM; Harun R; Muhammad R; Jamal R
    Asian Pac J Cancer Prev; 2016; 17(1):25-35. PubMed ID: 26838219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma.
    Chen W; Li G; Li Z; Zhu J; Wei T; Lei J
    Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
    Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
    Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
    Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer.
    Capriglione F; Verrienti A; Celano M; Maggisano V; Sponziello M; Pecce V; Gagliardi A; Giacomelli L; Aceti V; Durante C; Bulotta S; Russo D
    Endocrine; 2022 Jan; 75(1):185-193. PubMed ID: 34378123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report.
    Geraldo MV; Fuziwara CS; Friguglieti CU; Costa RB; Kulcsar MA; Yamashita AS; Kimura ET
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):552-7. PubMed ID: 23295297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma.
    Wang Z; Zhang H; He L; Dong W; Li J; Shan Z; Teng W
    Onco Targets Ther; 2013; 6():281-7. PubMed ID: 23569392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.